Rockwell Medical, Inc. Insider Trading

RMTI

Last 12 months

Insiders sold 16K and bought nothing on the open market.

72% of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in May 2020.

Net open-market

−16K

0 buys · 4 sales

Under a 10b5-1 plan

72%

of the value sold

Insiders who bought / sold

0 / 4

executives and directors

Last open-market buy

May 2020

May 14, 2020

Get an email when RMTI's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 1	Mark Strobeck President and CEO	Sold10b5-1 plan	1,000	$8.42	8K	1.6%	Form 4
Jan 2	Heather Hunter Chief Operating Officer	Sold10b5-1 plan	2,868	$0.84	2K	2.1%	Form 4
Jan 2	Jesse Neri SVP and CFO	Sold10b5-1 plan	886	$0.84	$744	0.7%	Form 4
Nov 18, 2025	John G Cooper Director	SoldNo plan	5,079	$0.87	4K	3.5%	Form 4
Oct 1, 2025	Heather Hunter SVP, Chief Operating Officer	Sold10b5-1 plan	2,868	$1.19	3K	2.1%	Form 4
Oct 1, 2025	Timothy Chole SVP and CCO	Sold10b5-1 plan	2,868	$1.19	3K	2.2%	Form 4
Oct 1, 2025	Jesse Neri SVP and CFO	Sold10b5-1 plan	886	$1.19	1K	0.7%	Form 4
Oct 1, 2025	Mark Strobeck President and CEO	Sold10b5-1 plan	6,926	$1.19	8K	2.1%	Form 4
Jul 1, 2025	Timothy Chole SVP and CCO	Sold10b5-1 plan	2,868	$0.82	2K	2.2%	Form 4
Jul 1, 2025	Mark Strobeck President and CEO	Sold10b5-1 plan	6,926	$0.82	6K	2.0%	Form 4
Jul 1, 2025	Jesse Neri SVP and CFO	Sold10b5-1 plan	886	$0.82	$727	0.7%	Form 4
Apr 10, 2025 – Apr 11, 2025	Irrevocable Larson Family Investment Trust Large holder	Bought 30 parts	87,500	$1.07 average	94K	2.5%	Form 4
Apr 1, 2025	Mark Strobeck President and CEO	Sold10b5-1 plan	6,926	$1.08	7K	5.3%	Form 4
Apr 1, 2025	Jesse Neri SVP, Finance and CFO	Sold10b5-1 plan	886	$1.10	$975	2.9%	Form 4
Apr 1, 2025	Timothy Chole SVP, Chief Commercial Officer	Sold10b5-1 plan	2,868	$1.08	3K	5.9%	Form 4
Jan 2, 2025	Timothy Chole SVP, Chief Commercial Officer	Sold10b5-1 plan	1,001	$2.05	2K	1.8%	Form 4
Jan 2, 2025	Mark Strobeck President and CEO	Sold10b5-1 plan	2,163	$2.06	4K	1.5%	Form 4
Nov 15, 2024	Mark H Ravich Director	SoldNo plan 2 parts	29,991	$2.35 average	70K	20%	Form 4

Oct 110b5-1 plan
Mark Strobeck
President and CEO · sold 1,000 at $8.42
8K
1.6% of stake
Jan 210b5-1 plan
Heather Hunter
Chief Operating Officer · sold 2,868 at $0.84
2K
2.1% of stake
Jan 210b5-1 plan
Jesse Neri
SVP and CFO · sold 886 at $0.84
$744
0.7% of stake
Nov 18, 2025No plan
John G Cooper
Director · sold 5,079 at $0.87
4K
3.5% of stake
Oct 1, 202510b5-1 plan
Heather Hunter
SVP, Chief Operating Officer · sold 2,868 at $1.19
3K
2.1% of stake
Oct 1, 202510b5-1 plan
Timothy Chole
SVP and CCO · sold 2,868 at $1.19
3K
2.2% of stake
Oct 1, 202510b5-1 plan
Jesse Neri
SVP and CFO · sold 886 at $1.19
1K
0.7% of stake
Oct 1, 202510b5-1 plan
Mark Strobeck
President and CEO · sold 6,926 at $1.19
8K
2.1% of stake
Jul 1, 202510b5-1 plan
Timothy Chole
SVP and CCO · sold 2,868 at $0.82
2K
2.2% of stake
Jul 1, 202510b5-1 plan
Mark Strobeck
President and CEO · sold 6,926 at $0.82
6K
2.0% of stake
Jul 1, 202510b5-1 plan
Jesse Neri
SVP and CFO · sold 886 at $0.82
$727
0.7% of stake
Apr 10, 2025 – Apr 11, 2025
Irrevocable Larson Family Investment Trust
Large holder · bought 87,500 at avg $1.07
94K
2.5% of stake
Apr 1, 202510b5-1 plan
Mark Strobeck
President and CEO · sold 6,926 at $1.08
7K
5.3% of stake
Apr 1, 202510b5-1 plan
Jesse Neri
SVP, Finance and CFO · sold 886 at $1.10
$975
2.9% of stake
Apr 1, 202510b5-1 plan
Timothy Chole
SVP, Chief Commercial Officer · sold 2,868 at $1.08
3K
5.9% of stake
Jan 2, 202510b5-1 plan
Timothy Chole
SVP, Chief Commercial Officer · sold 1,001 at $2.05
2K
1.8% of stake
Jan 2, 202510b5-1 plan
Mark Strobeck
President and CEO · sold 2,163 at $2.06
4K
1.5% of stake
Nov 15, 2024No plan
Mark H Ravich
Director · sold 29,991 at avg $2.35
70K
20% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch RMTI, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with RMTI

CompareIntrinsic value

LXRXLexicon Pharmaceuticals, Inc.

$1.48+1.37%40

DERMJourney Medical Corp

$4.73+1.94%25

VRDNViridian Therapeutics Inc.

$29.06+15.53%40

ASMBAssembly Biosciences Inc.

$19.87-0.25%19

FBIOFortress Biotech Inc.

$1.97+1.55%59

ENTAEnanta Pharmaceuticals Inc.

$10.65+2.70%25

PTGXProtagonist Therapeutics Inc.

$143.37+2.23%54

XLOXilio Therapeutics, Inc.

$8.71+0.35%40

Spot a number that looks wrong? Check it in RMTI's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing RMTI

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.